Deals
Bayer Says Monsanto-Syngenta Deal Would Prompt Industry Review
This article is for subscribers only.
A successful attempt by Monsanto Co. to buy Syngenta AG and form an agrochemical powerhouse would prompt major rivals to also reconsider strategy and review cross-licensing deals, said the head of Bayer AG’s CropScience unit.
“It would definitely force a review of how everybody is going to react,” Liam Condon said in a phone interview from the division’s headquarters in Monheim, Germany. “There’s only six research and development based players in this industry so if the two biggest were to go together, inevitably it would force others to review their strategies.”